header
Local cover image
Local cover image
Image from OpenLibrary

A study on the effect of stem cells as compared with dexamethasone on chemotherapy - induced pulmonary fibrosis in rat / Ebtehal Mohammad Fikry Elhady ; Supervised Ezz Eldin Aldenshary , Hala M. Fawzy , Marwa M. Safar

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ebtehal Mohammad Fikry Elhady , 2015Description: 136 P. : charts , photographs ; 25cmOther title:
  • دراسة عن تأثير الخلايا الجذعية فى التليف الرئوى الناجم عن العلاج الكيميائى فى الجرذان و ذلك بالمقارنة بتأثير دواء ديكساميثازون [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology Summary: Mesenchymal stem cells (MSCs) have recently emerged as a remedy for various pathological conditions including systemic and pulmonary inflammation. The present study examined the therapeutic effects of bone marrow mesenchymal stem cells (BM - MSCs) and adipose derived mesenchymal stem cells (AD-MSCs) in methotrexate (MTX) - induced pulmonary fibrosis in rats as compared with dexamethasone (Dex.). Methotrexate (14 mg/kg, as a single dose / week for 2 weeks, p.o.) induced lung fibrosis as marked by elevation of relative lung weight, malondialdehyde, nitrite/nitrate, interleukin - 4, transforming growth factor-Ý1, deposited collagen, as well as increased expression of Bax along with the reduction of reduced glutathione content and superoxide dismutase activity. These deleterious effects were antagonize after treatment either with BM - MSCs or AD - MSCs (2{u00D7}106 cells / rat) 2 weeks after MTX to even a better extent than Dex. (0.5 mg / kg / for 7 days, p.o.). In conclusion, BM-MSC and AD-MSCs possessed antioxidant, antiapoptotic, as well as antifibrotic effects which will probably introduce them as remarkable candidates for the treatment of pulmonary fibrosis
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.09.Ph.D.2015.Eb.S (Browse shelf(Opens below)) Not for loan 01010110067468000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.09.Ph.D.2015.Eb.S (Browse shelf(Opens below)) 67468.CD Not for loan 01020110067468000

Thesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology

Mesenchymal stem cells (MSCs) have recently emerged as a remedy for various pathological conditions including systemic and pulmonary inflammation. The present study examined the therapeutic effects of bone marrow mesenchymal stem cells (BM - MSCs) and adipose derived mesenchymal stem cells (AD-MSCs) in methotrexate (MTX) - induced pulmonary fibrosis in rats as compared with dexamethasone (Dex.). Methotrexate (14 mg/kg, as a single dose / week for 2 weeks, p.o.) induced lung fibrosis as marked by elevation of relative lung weight, malondialdehyde, nitrite/nitrate, interleukin - 4, transforming growth factor-Ý1, deposited collagen, as well as increased expression of Bax along with the reduction of reduced glutathione content and superoxide dismutase activity. These deleterious effects were antagonize after treatment either with BM - MSCs or AD - MSCs (2{u00D7}106 cells / rat) 2 weeks after MTX to even a better extent than Dex. (0.5 mg / kg / for 7 days, p.o.). In conclusion, BM-MSC and AD-MSCs possessed antioxidant, antiapoptotic, as well as antifibrotic effects which will probably introduce them as remarkable candidates for the treatment of pulmonary fibrosis

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image